Reply to “Considerations of clinical trial design to evaluate intranasal corticosteroids in patients with chronic rhinosinusitis”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to “Considerations of clinical trial design to evaluate intranasal corticosteroids in patients with chronic rhinosinusitis”

Published:2024-07 Issue:7 Volume:12 Page:1948-1949
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Palmer James N.

Publisher

Elsevier BV

Reference8 articles.

1. Considerations of clinical trial design to evaluate intranasal corticosteroids in patients with chronic rhinosinusitis;Lipworth;J Allergy Clin Immunol Pract,2024

2. Efficacy of EDS-FLU for chronic rhinosinusitis: two randomized controlled trials (ReOpen1 and ReOpen2);Palmer;J Allergy Clin Immunol Pract,2024

3. NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps;Sindwani;Am J Rhinol Allergy,2019

4. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis;Leopold;J Allergy Clin Immunol,2019

5. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis;Palmer;Int Forum Allergy Rhinol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP